Experimental allergic encephalomyelitis in pituitary-grafted Lewis rats

Journal of Neuroinflammation

Volumn 3, Issue , 2006, Pages

  Esquifino, Ana I ^a   Cano, Pilar ^a   Zapata, Agustín ^a   Cardinali, Daniel P ^b  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; BROMOCRIPTINE; DOPAMINE RECEPTOR STIMULATING AGENT; FREUND ADJUVANT; PROLACTIN; SODIUM CHLORIDE;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DECAPITATION; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; ECTOPIC ORGAN; HYPOPHYSIS DISEASE; HYPOPHYSIS GRAFT; IMMUNIZATION; MALE; NONHUMAN; PROLACTIN BLOOD LEVEL; PROLACTIN RELEASE; RAT; RAT STRAIN; SPINAL CORD; TISSUE HOMOGENATE;

EID: 33748875807     PISSN: 17422094     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-3-20     Document Type: Article

References (27)

1. Wekerle H, Kojima K, Lannes-Vieira J, Lassmann H, Linington C: Animal models. Ann Neurol 1994, 36(Suppl):S47-S53.
2. Coyle PK: The neuroimmunology of multiple sclerosis. Adv Neuroimmunol 1996, 6:143-154.
3. Takagi K, Suzuki F, Barrow RE, Wolf SE, Herndon DN: Recombinant human growth hormone modulates Th1 and Th2 cytokine response in burned mice. Ann Surg 1998, 228:106-111.
4. Majumder B, Biswas R, Chattopadhyay U: Prolactin regulates antitumor immune response through induction of tumoricidal macrophages and release of IL-12. Int J Cancer 2002, 97:493-500.
5. Nagy E, Berczi I, Wren GE, Asa SL, Kovacs K: Immunomodulation by bromocriptine. Immunopharmacology 1983, 6:231-243.
6. Vera-Lastra O, Jara LJ, Espinoza LR: Prolactin and autoimmunity. Autoimmun Rev 2002, 1:360-364.
7. Yu-Lee LY: Prolactin modulation of immune and inflammatory responses. Recent Prog Horm Res 2002, 57:435-455.
8. Arce A, Castrillon P, Della Maggiore V, Cardinali DP, Esquifino AI: Effect of cyclosporine on immune responses in submaxillary lymph nodes of pituitary-grafted rats. Biol Signals 1996, 5:334-342.
9. Matera L, Mori M, Geuna M, Buttiglieri S, Palestro G: Prolactin in autoimmunity and antitumor defence. J Neuroimmunol 2000, 109:47-55.
10. Canonico PL, Sortino MA, Favit A, Aleppo G, Scapagnini U: Dihydro-ergocryptine protects from acute experimental allergic encephalomyelitis in the rat. Funct Neurol 1993, 8:183-188.
11. Dijkstra CD, van der Voort ER, De Groot CJ, Huitinga I, Uitdehaag BM, Polman CH, Berkenbosch F: Therapeutic effect of the D2-dopamine agonist bromocriptine on acute and relapsing experimental allergic encephalomyelitis. Psychoneuroendocrinology 1994, 19:135-142.
12. Bartke A, Shrenker P: Effect of experimentally-induced chronic hyperprolactinemia on testosterone and gonadotropin levels in male rats and mice. Critical Rev Anat Sci 1987, 1:37-62.
13. Tresguerres JA, Esquifino AI: Dissociation in the regulation of luteinizing hormone and follicle-stimulating hormone in a hyperprolactinaemic rat model: interrelationships between gonadotrophin and prolactin control. J Endocrinol 1981, 90:41-51.
14. Esquifino AI, Cano P, Jimenez V, Cutrera RA, Cardinali DP: Experimental allergic encephalomyelitis in male Lewis rats subjected to calorie restriction. J Physiol Biochem 2004, 60:245-252.
15. Castrillón P, Cardinali DP, Pazo D, Cutrera RA, Esquifino AI: Effect of superior cervical ganglionectomy on 24-h variations in hormone secretion from anterior hypophysis and in hypothalamic monoamine turnover, during the preclinical phase of Freund's adjuvant arthritis in rats. J Neuroendocrinol 2001, 13:288-295.
16. Stefferl A, Linington C, Holsboer F, Reul JM: Susceptibility and resistance to experimental allergic encephalomyelitis: relationship with hypothalamic-pituitary-adrenocortical axis responsiveness in the rat. Endocrinology 1999, 140:4932-4938.
17. 3 to suppress experimental autoimmune encephalomyelitis in mice. Proc Natl Acad Sci U S A 2002, 99:5557-5560.
18. Neidhart M, Fluckiger EW: Hyperprolactinaemia in hypophysectomized or intact male rats and the development of adjuvant arthritis. Immunology 1992, 77:449-455.
19. Selgas L, Arce A, Esquifino AI, Cardinali DP: Twenty-hour hour rhythms of serum ACTH, prolactin, growth hormone and thyroid-stimulating hormone, and of median eminence norepinephrine, dopamine and serotonin, in rats injected with Freund's adjuvant. Chronobiol Int 1997, 14:253-265.
20. Chikanza IC: Prolactin and neuroimmunomodulation: in vitro and in vivo observations. Ann N Y Acad Sci 1999, 876:119-130.
21. Riskind PN, Massacesi L, Doolittle TH, Hauser SL: The role of prolactin in autoimmune demyelination: suppression of experimental allergic encephalomyelitis by bromocriptine. Ann Neurol 1991, 29:542-547.
22. Kira J, Harada M, Yamaguchi Y, Shida N, Goto I: Hyperprolactinemia in multiple sclerosis. J Neurol Sci 1991, 102:61-66.
23. Azar ST, Yamout B: Prolactin secretion is increased in patients with multiple sclerosis. Endocr Res 1999, 25:207-214.
24. Yamasaki K, Horiuchi I, Minohara M, Osoegawa M, Kawano Y, Ohyagi Y, Yamada T, Kira J: Hyperprolactinemia in optico-spinal multiple sclerosis. Intern Med 2000, 39:296-299.
25. Wei T, Lightman SL: The neuroendocrine axis in patients with multiple sclerosis. Brain 1997, 120:1067-1076.
26. Heesen C, Gold SM, Bruhn M, Monch A, Schulz KH: Prolactin stimulation in multiple sclerosis - an indicator of disease sub-types and activity? Endocr Res 2002, 28:9-18.
27. Harirchian MH, Sahraian MA, Shirani A: Serum prolactin level in patients with multiple sclerosis: a case control study. Med Sci Monit 2006, 12:CR177-CR180.